Indian Patent Office rejects anti-cancer drug patent

24-06-2014

Indian Patent Office rejects anti-cancer drug patent

Supoj Pongpancharoen / Shutterstock.com

The Indian Patent Office (IPO) has rejected a patent application for an anti-cancer drug for the second time, paving the way for generic versions to potentially enter the market.


patent, IPO, Abraxane, Abraxis, Natco Pharma

LSIPR